6.69BMarket Cap47.56P/E (TTM)
32.590High32.170Low1.11MVolume32.350Open32.370Pre Close35.93MTurnover1.18%Turnover Ratio87.41P/E (Static)206.97MShares32.59052wk High2.61P/B3.04BFloat Cap11.89052wk Low--Dividend TTM94.07MShs Float32.590Historical High--Div YieldTTM1.30%Amplitude8.750Historical Low32.366Avg Price1Lot Size
Life Time Stock Forum
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology (CLVS.US)$ +11.3%, $Cardiff Oncology (CRDF.US)$ +9%, $Immatics (IMTX.US)$ +8.3%, $IDEAYA Biosciences (IDYA.US)$ +8%, $Lyra Therapeutics (LYRA.US)$ +5.7%, $POINT Biopharma (PNT.US)$ +5.7%, $Edgewise Therapeutics (EWTX.US)$ +4.7%, $Concert Pharmaceuticals (CNCE.US)$ +3.6%, $Deciphera Pharmaceuticals (DCPH.US)$ +3.2%, $Veracyte (VCYT.US)$ +2.6%, $SpringWorks Therapeutics (SWTX.US)$ +2.3%, ...
No comment yet